Pulmonary
Partner With Us
Advertisement
Conexiant chevron_right Pulmonary chevron_right FDA Approves First Therapy for Noncystic Fibrosis Bronchiectasis
FDA & Government News

FDA Approves First Therapy for Non-cystic Fibrosis Bronchiectasis

Brensocatib (Brinsupri) will offer a new treatment option for patients 12 years and older.

Conexiant

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.